Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

Background: Checkpoint inhibitors plus platinum-based chemotherapy have shown superiority compared to chemotherapy alone as first-line therapy in advanced non–small cell lung carcinoma (NSCLC). To evaluate the relative benefit in term of Overall Survival (OS) and Progression-free Survival (PFS) of c...

Full description

Bibliographic Details
Main Authors: Alfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, Massimo Di Maio
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Oncology
Subjects:
NCSLC
checkpoint inhibition
first line
PDL1
PD1
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00264/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00264/full

Similar Items